Hashmi, A. H. http://orcid.org/0000-0002-1592-0606
Nyein, P. B.
Pilaseng, K.
Paw, M. K.
Darakamon, M. C.
Min, A. M.
Charunwatthana, P.
Nosten, F.
McGready, R.
Carrara, V. I.
Funding for this research was provided by:
Wellcome Trust (106698/Z/14/Z)
Article History
Received: 10 July 2019
Accepted: 21 October 2019
First Online: 28 November 2019
Ethics approval and consent to participate
: This investigation was part of a larger study (ClinicalTrials.gov Identifier: NCT00840502), and was approved by the University of Oxford (OxTREC (14–08) and Mahidol University (TMEC 2008–028) Ethics Committees. The current study also received ethical approval by the University of Texas Medical Branch (Galveston, Texas) Institutional Review Board (14–0211). All institutions approved this study in accordance with the Declaration of Helsinki. In addition, the Tak Province Community Advisory Board (Tak, Thailand) based along the Thailand-Myanmar border also approved this study (TCAB-03.13). Written, informed consent was obtained from all participants included in this study.
: As part of the ethics approved consent forms, participants consented to publication of anonymised data.
: The authors declare that they have no competing interests.